Navigation Links
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
Date:5/21/2008

TOKYO, May 21 /PRNewswire/ -- Daiichi Sankyo Co., Ltd. announced today that it has entered into an agreement to acquire the privately held firm, U3 Pharma AG, a German biotechnology company focusing on research into antibodies for the treatment of cancer.

Daiichi Sankyo will purchase 100 percent of the stock and make a one-time payment of 150 million Euros ($235 million dollars) for the company. Closure of the transaction is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act and customary closing conditions.

U3 Pharma, which is based in Martinsried, Germany, was founded by Professor Axel Ullrich of the Max Planck Institute of Biochemistry, whose pioneering gene technology-based and oncology-focused research led to the development of the oncology blockbusters Herceptin(R) and Sutent(TM)*. U3 Pharma was established in 2001 and currently employs 27 people, the majority of whom work directly in research and development.

U3 Pharma's investors include Alta Partners, Atlas Venture, E. de Rothschild Investment Partners, Life Science Partners and Karsten Henco, as well as private individuals from the biotech and pharmaceutical industries.

U3 Pharma's pipeline of novel targeted therapeutics includes programs focusing on fully-human antibodies as potential therapies for breast, lung and colorectal cancers, among others. The company's lead product, which is being co-developed with Amgen, is U3-1287 (AMG 888), the first fully-human anti-HER3 monoclonal antibody (mAb) to inhibit oncogenic signaling and tumor proliferation. The companies intend to initiate clinical development of this compound this year.

Daiichi Sankyo's current novel therapeutics portfolio for worldwide commercialization includes CS-1008, an oncologic agent to combat malignant neoplasms, which is in Phase 2. For commercialization only in Japan, Daiichi Sankyo has the rights to market denosumab, or AMG 162, which is licensed from Amgen. In Japan, t
'/>"/>

SOURCE Daiichi Sankyo Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin
2. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
3. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Drug Discovery Technologies - A Global U... http://www.reportlinker.com/p0164246/Drug-Discove...--Opportunities.html ,, Drug discovery has bec...aceutical company,s business strategy. There are a...
(Date:12/2/2009)...wswire-FirstCall/ - Oncolytics Biotech Inc. ("Onco... announced today that in connection with its previ...ve exercised in full their over-allotment option a...t is comprised of one common share and 0.4 of a co...ce of US$3.00 per unit. Each whole common share pu...
(Date:12/2/2009)..., December 2 Gamida Cell announced...cal (animal study) safety and,efficacy of a gene t...l,Cornell Medical College and Gamida Cell. The pro... such as Cooley,s Anemia. , Gamida Cell i...x vivo,populations of stem/progenitor cells. The ...
(Date:12/2/2009)...ire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: A...aceutical company focused on endocrine therapy and...Drug Administration (FDA) has granted Fast Track d...bitor compound, perifosine (KRX-0401), for the tre...ryx Biopharmaceuticals, Inc. ("Keryx") ( KERX), is...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
... protection firms could be the answer to a questio...The Internet does connect you with your customers ...r disparaging websites and e-mails that could dama...ential brand threats to small businesses online, r...uggestions for dealing with them. , , Bad reviews ...
... Wisconsin women entrepreneurs who are poised to...nue level will have a chance to compete for cash, ...ake Mine a Million campaign holds its first state... which will take place at the Madison Concourse H...g those in the technology and life science fields....
.... - GE Healthcare,s efforts to create an early ...Electric Co.,s pending acquisition of Abbott Lab... diagnostics business units, according to GE execu...entered into a definitive agreement for GE, the pa...aboratory diagnostics business units for $8.13 bil...
Other Biology Technology:Protecting your business against online brand abuse 2Protecting your business against online brand abuse 3Women's entrepreneurial event set for May 21 2GE acquisition may boost "early" healthcare strategy 2
(Date:12/2/2009)...ke their first cigarette within minutes after waki...oduct of nicotine when processed by the body, than... of cigarettes smoked. , "Since cotinine leve...results suggest that smokers who smoke immediately...ancer," said researcher Joshua E. Muscat, Ph.D., M...
(Date:12/2/2009)...moky Mountain forest,s woodland herb population ha... understories recover from logging, according to P...ng in portions of the forest nearly 80 years ago, ...ry forest floor was similar to that of undisturbed...sor of forestry and natural resources, said that c...
(Date:12/2/2009)...dical Center researchers have figured out how stem... better able to resist radiation therapy. And usin...n these cancer stem cells, they were able to kill ...ory experiment. , The work builds off earlier r... the effects of radiation much better than other c...
Breaking Biology News(10 mins):Increased nicotine levels detected in those who light-up earlier 2Study finds logging effects vary based on a forest's history, climate 2Discovery makes brain tumor cells more responsive to radiation 2Kendle to Present at Upcoming Jefferies and Wachovia Securities Conferences 48200 1Kendle to Present at Upcoming Jefferies and Wachovia Securities Conferences 48200 2Concussion Experts 3A For Kids No Sports No Schoolwork No Text Messages 48196 1Concussion Experts 3A For Kids No Sports No Schoolwork No Text Messages 48196 2Concussion Experts 3A For Kids No Sports No Schoolwork No Text Messages 48196 3Robot Speaks Many Languages Improves Pharmacy Patient Outcomes 48192 1Robot Speaks Many Languages Improves Pharmacy Patient Outcomes 48192 2
...n the oldest synthetic malaria drug, the methylene...tes and make a significant contribution to the lon... "Roll Back Malaria Initiative." In a study on 160...s in tropical medicine from the Heidelberg Univers...ewer malaria drugs, methylene blue prevents the ma...
...s hope to turn plants into a renewable, nonpolluti...entists have to learn how to convert plant biomass...ply and efficiently. In new research, chemists hav...mon plant carbohydrate -- directly into the buildi...ilds upon earlier work by researchers at the Depar...
...eart disease are twice as likely to suffer from de... the medical community has largely been unable to ...riam Hospital, in conjunction with The Montral Hea...versity, reveals there may be genetic variations t...ents. , According to the study, published in the ...
Other Biology News:Old stain in a new combination 2Old stain in a new combination 3Plastic that grows on trees, part two 2Genetic factors may predict depression in heart disease patients 2Genetic factors may predict depression in heart disease patients 3
Corning C ulture Dishes, 150X25 mm, Tc-Treated, PS, Sterile from Sigma-Aldrich
...ade; Colorimetric Detection System is intended for... generated by an in-house validated in vitro nucle...rest. • The CHEMICON XpressPack™ Co...ture assay designed to detect amplified nucleic ac...
... is optimized for maximum packaging efficiencies o...cteriophage l vector. Using a test insert with Nov...ms (> 4 x 10^8 pfu/g ligated l control DNA) are ty...y easy to use; simply add up to 5 g of ligated vec...
BD BioCoat Laminin 150 mm Culture Dishes from BD Biosciences - Discovery Labware
Biology Products: